Comparison of the rhythm control treatment strategy versus the rate control strategy in patients with permanent or long-standing persistent atrial fibrillation and heart failure treated with cardiac resynchronization therapy - a pilot study of Cardiac Resynchronization in Atrial Fibrillation Trial (Pilot-CRAfT): study protocol for a randomized controlled trial
Authors:
- Jan CiszewskiJCJan Ciszewski
- Aleksander MaciagAMAleksander Maciag
- Ilona KowalikIKIlona Kowalik
- Pawel SyskaPSPawel Syska
- Michal LewandowskiMLMichal Lewandowski
- Michal M FarkowskiMFMichal M Farkowski
- Tomasz ChwyczkoTCTomasz Chwyczko
- Mariusz PytkowskiMPMariusz Pytkowski
- Hanna SzwedHSHanna Szwed
- Maciej SterlinskiMSMaciej Sterlinski
Open Access
- 4 October 2014
- journal article
- research article
- Published by Springer Nature in Trials
- Vol. 15 (1) , 1-9
Abstract
The only subgroups of patients with heart failure and atrial fibrillation in which the efficacy of cardiac resynchronization therapy has been scientifically proven are patients with indications for right ventricular pacing and patients after atrioventricular junction ablation. However it is unlikely that atrioventricular junction ablation would be a standard procedure in the majority of the heart failure patients with cardiac resynchronization therapy and concomitant atrial fibrillation due to the irreversible character of the procedure and a spontaneous sinus rhythm resumption that occurs in about 10% of these patients. Pilot-CRAfT is the first randomized controlled trial evaluating the efficacy of a rhythm control strategy in atrial fibrillation patients with cardiac resynchronization therapy devices. The aim of this prospective, single center randomized controlled pilot study is to answer the question whether the patients with cardiac resynchronization therapy and permanent atrial fibrillation would benefit from a strategy to restore and maintain sinus rhythm (that is ‘rhythm control’ strategy) in comparison to rate control strategy. The study population consists of 60 patients with heart failure and concomitant long-standing persistent or permanent atrial fibrillation who underwent a cardiac resynchronization therapy device implantation at least 3 months before qualification. Study participants are randomly assigned to the rhythm control strategy (including electrical cardioversion and pharmacotherapy) or to the rate control group whose goal is to control ventricular rate. The follow-up time is 12 months. The primary endpoint is the ratio of effectively captured biventricular beats. The secondary endpoints include peak oxygen consumption, six-minute walk test distance, heart failure symptom escalation, reverse remodelling of the heart on echo and quality of life. NCT01850277 registered on 22 April 2013 (ClinicalTrails.gov)Keywords
This publication has 24 references indexed in Scilit:
- 2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapyEuropean Heart Journal, 2013
- ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESCEuropean Heart Journal, 2012
- Outcomes of cardiac resynchronization therapy in patients with versus those without atrial fibrillation: A systematic review and meta-analysisHeart Rhythm, 2011
- Cardiac resynchronization therapy in patients undergoing atrioventricular junction ablation for permanent atrial fibrillation: a randomized trialEuropean Heart Journal, 2011
- Guidelines for the management of atrial fibrillation: The Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC)European Heart Journal, 2010
- Extending the Boundaries of Cardiac Resynchronization Therapy: Efficacy in Atrial Fibrillation, New York Heart Association Class II, and Narrow QRS Heart Failure PatientsJournal of Cardiac Failure, 2010
- Cardiac Resynchronization in Patients With Atrial FibrillationJACC, 2008
- Long-term survival in patients undergoing cardiac resynchronization therapy: the importance of performing atrio-ventricular junction ablation in patients with permanent atrial fibrillationEuropean Heart Journal, 2008
- Management of atrial fibrillation in patients with heart failureEuropean Heart Journal, 2007
- Comparative effects of permanent biventricular and right-univentricular pacing in heart failure patients with chronic atrial fibrillationEuropean Heart Journal, 2002